These differences matter because access challenges, such as refill difficulty and medication switching, show up across every care pathway, suggesting that no single model has solved the problem of continuity
These effects contribute to the medication's weight loss efficacy, with clinical trials showing weight reductions that vary by dose and indication, generally ranging from 5-15% in type 2 diabetes and 15-20% in obesity at the highest doses
Abbreviations GLP-1 RAs: Glucagon-like peptide-1 receptor agonists T2DM: Type 2 diabetes mellitus COPD: Chronic obstructive pulmonary disease BMI: Body mass index HbA1c: Glycated hemoglobin RR: Relative risk CI: Confidence interval RCT: Randomized controlled trial CVOT: Cardiovascular outcome trial PRISMA: Preferred reporting items for systematic reviews and meta-analyses References Zar HJ, Ferkol TW
Margaritelis NV, Paschalis V, Theodorou AA, Kyparos A, Nikolaidis MG (2020) Antioxidant supplementation, redox deficiencies and exercise performance: a falsification design
la equivalencia de dosis debe hacerse con precaucin debido a la diferente biodisponibilidad
